Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization

Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model

(2015) Ramaswamy Bhuvaneswari et al.   LASERS IN SURGERY AND MEDICINE

mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: Development of a new method

(2012) Baris Karakullukcu et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1

(2012) J R van Beijnum et al.   ONCOGENE

Antiangiogenic Therapy for Cancer: An Update

(2012) Belal Al-Husein et al.   PHARMACOTHERAPY

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers

(2012) Y Adar et al.   Cell Death & Disease

Third Generation Tyrosine Kinase Inhibitors and Their Development in Advanced Renal Cell Carcinoma

(2012) Ronald M. Bukowski   Frontiers in Oncology

Photodynamic therapy of cancer: An update

(2011) Patrizia Agostinis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion

(2011) Patrycja Nowak-Sliwinska et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?

(2011) Anne Q. Reuwer et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

(2011) Brian I Rini et al.   LANCET

Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement

(2011) C. Porta et al.   MEDICAL ONCOLOGY

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane

(2010) Patrycja Nowak-Sliwinska et al.   ANGIOGENESIS

Angiostasis-induced vascular normalization can improve photodynamic therapy

(2010) Patrycja Nowak-Sliwinska et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The Neovessel Occlusion Efficacy of 151-Hydroxypurpurin-7-Lactone Dimethyl Ester Induced with Photodynamic Therapy

(2010) Siang Hui Lim et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

One-Year Results of Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

(2009) Ayana Yamashita et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

(2009) Kristy J. Gotink et al.   ANGIOGENESIS

Sunitinib

(2009) Georgios S. Papaetis et al.   BIODRUGS

Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model

(2009) Patrycja Nowak-Sliwinska et al.   MICROVASCULAR RESEARCH

Combination Therapy Using Verteporfin and Ranibizumab; Optimizing the Timing in the CAM Model

(2009) Elodie Debefve et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results

(2008) Andrew N. Antoszyk et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Axitinib for renal cell carcinoma

(2008) Guru Sonpavde et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients

(2007) Fumi Gomi et al.   OPHTHALMOLOGY